Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
BlackRock TCP Capital
TCPC
$351M
| $627K | ﹤0.01% |
45,002
-1,930
| -4% | -$28.3K |
|
|
BHBK
2527
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $627K | ﹤0.01% |
40,939
+10,318
| +34% | +$154K |
|
|
MPT
2528
Medical Properties Trust
MPT
$2.45B
| $626K | ﹤0.01% |
+54,368
| New | +$621K |
|
|
VRTV
2529
DELISTED
VERITIV CORPORATION
VRTV
| $623K | ﹤0.01% |
17,199
-76,506
| -82% | -$3.03M |
|
|
CDI
2530
DELISTED
CDI Corp.
CDI
| $623K | ﹤0.01% |
92,187
+66,224
| +255% | +$499K |
|
2531
Thermo Fisher Scientific
TMO
$232B
| $622K | ﹤0.01% |
4,383
-3,517
| -45% | -$469K |
|
|
MHGC
2532
DELISTED
Morgans Hotel Group Co.
MHGC
| $622K | ﹤0.01% |
184,700
+179,620
| +3,536% | +$611K |
|
|
FPI
2533
Farmland Partners
FPI
$448M
| $621K | ﹤0.01% |
56,630
-7,321
| -11% | -$78.9K |
|
|
STKL
2534
DELISTED
SunOpta
STKL
| $621K | ﹤0.01% |
90,823
-81,951
| -47% | -$508K |
|
|
PCO
2535
DELISTED
Pendrell Corporation - Class A
PCO
| $621K | ﹤0.01% |
1,240
-344
| -22% | -$216K |
|
|
DRD
2536
DRDGold
DRD
$2.71B
| $620K | ﹤0.01% |
387,597
-74,363
| -16% | -$117K |
|
|
STR
2537
DELISTED
QUESTAR CORP
STR
| $619K | ﹤0.01% |
31,756
-185,357
| -85% | -$3.63M |
|
|
AXLL
2538
CALL
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $616K | ﹤0.01% |
+40,000
| New | +$737K |
|
2539
Ubiquiti
UI
$34.9B
| $613K | ﹤0.01% |
+19,352
| New | +$640K |
|
2540
Vanguard Health Care ETF
VHT
$19.8B
| $609K | ﹤0.01% |
4,582
-2,261
| -33% | -$295K |
|
|
PZE
2541
DELISTED
Petrobras Argentina S A
PZE
| $609K | ﹤0.01% |
109,954
+39,865
| +57% | +$226K |
|
|
CPRX
2542
DELISTED
Catalyst Pharmaceutical
CPRX
| $607K | ﹤0.01% |
247,829
+234,127
| +1,709% | +$671K |
|
2543
Rollins
ROL
$17.5B
| $606K | ﹤0.01% |
52,628
-121,077
| -70% | -$1.44M |
|
2544
Mizuho Financial
MFG
$126B
| $604K | ﹤0.01% |
149,600
-11,400
| -7% | -$46.2K |
|
|
XNET
2545
Xunlei
XNET
$323M
| $604K | ﹤0.01% |
79,931
+54,893
| +219% | +$405K |
|
|
DNY
2546
DELISTED
DONNELLEY R R & SONS CO
DNY
| $604K | ﹤0.01% |
41,013
-191
| -0.5% | -$2.81K |
|
2547
Kelly Services Class A
KELYA
$591M
| $602K | ﹤0.01% |
37,280
+15,138
| +68% | +$242K |
|
|
GCAP
2548
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $602K | ﹤0.01% |
74,216
-32,684
| -31% | -$253K |
|
2549
Embotelladora Andina Series B
AKO.B
$4.8B
| $600K | ﹤0.01% |
34,455
+13,181
| +62% | +$265K |
|
2550
POSCO
PKX
$18B
| $600K | ﹤0.01% |
+16,981
| New | +$640K |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.